baudax bio.jpg
Baudax Bio Reports First Quarter 2021 Financial Results
May 05, 2021 07:00 ET | Baudax Bio, Inc.
ANJESO® Demonstrates Continued Progress with Launch; Growth in End-User Unit Sales Increased 40% in Q1 compared to Q4’20 Average Sales per Account Increased 30% in Q1 compared to Q4’20 Richard S....
baudax bio.jpg
Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021
April 29, 2021 07:00 ET | Baudax Bio, Inc.
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings,...
baudax bio.jpg
Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine
April 26, 2021 07:00 ET | Baudax Bio, Inc.
Patients Administered ANJESO Prior to the Start of Surgery had Significantly Lower Summed Pain Intensity Scores on the First Postsurgical Day and Throughout Their Inpatient Course ANJESO Treated TKA...
baudax bio.jpg
Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders
April 08, 2021 16:05 ET | Baudax Bio, Inc.
MALVERN, Pa., April 08, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it has...
baudax bio.jpg
Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2021 07:00 ET | Baudax Bio, Inc.
MALVERN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation...
baudax bio.jpg
Baudax Bio to Participate at the Oppenheimer 31st Annual Healthcare Conference
March 10, 2021 07:00 ET | Baudax Bio, Inc.
MALVERN, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood,...
baudax bio.jpg
Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer
March 08, 2021 07:00 ET | Baudax Bio, Inc.
MALVERN Pa., March 08, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced the appointment of Richard...
baudax bio.jpg
Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference
March 02, 2021 07:00 ET | Baudax Bio, Inc.
MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood,...
baudax bio.jpg
Baudax Bio Reports 2020 Annual Financial Results
February 16, 2021 07:00 ET | Baudax Bio, Inc.
Deepening Usage of ANJESO Evidenced by a Reorder Rate of 60% by the End of 2020 and 58% Growth in Vials Sold from the Sequential Quarter Secured Approximately $55 Million in Gross Proceeds from...
baudax bio.jpg
Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021
February 10, 2021 08:05 ET | Baudax Bio, Inc.
MALVERN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, (“Baudax Bio” or the “Company”) today...